(NASDAQ: QURE) Uniqure Nv's forecast annual revenue growth rate of 76.88% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 33.61%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.79%.
Uniqure Nv's revenue in 2026 is $18,093,000.On average, 15 Wall Street analysts forecast QURE's revenue for 2026 to be $1,440,082,952, with the lowest QURE revenue forecast at $797,299,145, and the highest QURE revenue forecast at $2,330,974,246. On average, 16 Wall Street analysts forecast QURE's revenue for 2027 to be $2,957,360,507, with the lowest QURE revenue forecast at $618,061,353, and the highest QURE revenue forecast at $8,463,025,812.
In 2028, QURE is forecast to generate $6,798,674,883 in revenue, with the lowest revenue forecast at $1,755,294,243 and the highest revenue forecast at $15,526,584,132.